Lyra Therapeutics, Inc.
Biotechnology · Healthcare
1 appearance
Latest appearance 2021-11-09
Robert Kern
CMO
Equibles does not estimate personal net worth.
About Robert Kern
Robert Kern has spoken on 1 earnings call across 1 company, most recently for Lyra Therapeutics, Inc. on November 9, 2021. The companies whose calls Robert Kern spoke on are classified in the Healthcare sector.
Robert Kern on recent calls
“As Maria mentioned, new positive data on LYR-210 was a subject of two presentations at the 67th Annual Meeting of the American Rhinologic Society. Before I review these data, I wanted to remark on the award that the LANTERN manuscript received at that meeting.”
Company network
Recent activity
-
Earnings call
Lyra Therapeutics, Inc. Q3 FY2021 Earnings Call
Lyra Therapeutics, Inc.